May 5, 2020 / 9:56 PM / a month ago

BRIEF-Clovis Oncology Announces First Quarter 2020 Operating Results

May 5 (Reuters) - Clovis Oncology Inc:

* CLOVIS ONCOLOGY ANNOUNCES FIRST QUARTER 2020 OPERATING RESULTS

* Q1 LOSS PER SHARE $1.39

* Q1 EARNINGS PER SHARE ESTIMATE $-1.28 — REFINITIV IBES DATA

* PLAN TO SUBMIT IND FOR FAP-2286, A RADIOPHARMACEUTICAL THERAPY TARGETING FAP IN 2H 2020

* $228.4M IN CASH, CASH EQUIVALENTS AND AVAILABLE FOR SALE SECURITIES AT MARCH 31

* CONTINUE TO ANTICIPATE CASH RUNWAY INTO 2H 2021

* $42.6 MILLION IN RUBRACA GLOBAL SALES FOR Q1 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below